Related Experiment Videos
Service plans and clinical interventions targeted by the oncology pharmacist
1Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Pharmacy Practice Management Quarterly
|March 8, 1996
Summary
Oncology pharmacists enhance patient care by optimizing cancer treatment regimens, preventing adverse drug reactions, and reducing costs. Their interventions improve patient outcomes in complex oncology settings.
Area of Science:
- Oncology Pharmacy Practice
- Clinical Pharmacy Services
- Health Outcomes Research
Background:
- Healthcare systems increasingly demand demonstrable value from clinical services.
- Oncology pharmacotherapy presents unique challenges due to toxicity, complexity, and cost.
- Pharmacists are positioned to significantly impact patient care in oncology.
Purpose of the Study:
- To describe pharmacist-led programs on an adult inpatient oncology unit.
- To highlight pharmacist contributions to chemotherapy quality improvement.
- To illustrate pharmacist roles in managing febrile neutropenia and stem cell transplant patients.
Main Methods:
- Implementation of structured programs by pharmacists.
- Focus on chemotherapy quality improvement initiatives.
- Management protocols for febrile neutropenia and peripheral blood cell transplant patients.
Main Results:
- Pharmacist interventions aimed at optimizing drug regimens and reducing costs.
- Proactive management of treatment toxicities and complications.
- Contribution to improved patient outcomes in complex cancer care.
Conclusions:
- Pharmacist-led programs are essential for value-added care in oncology.
- Oncology pharmacists play a critical role in enhancing patient safety and treatment efficacy.
- These services demonstrate significant benefits in managing complex cancer therapies.